Single-cell and spatial architecture of primary liver cancer

Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a...

Full description

Saved in:
Bibliographic Details
Published inCommunications biology Vol. 6; no. 1; pp. 1181 - 17
Main Authors Zhou, Pei-Yun, Zhou, Cheng, Gan, Wei, Tang, Zheng, Sun, Bao-Ye, Huang, Jin-Long, Liu, Gao, Liu, Wei-Ren, Tian, Meng-Xin, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qu, Wei-Feng, Huang, Run, Zhu, Gui-Qi, Huang, Cheng, Fu, Xiu-Tao, Ding, Zhen-Bin, Gao, Qiang, Zhou, Jian, Shi, Ying-Hong, Yi, Yong, Fan, Jia, Qiu, Shuang-Jian
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 20.11.2023
Nature Publishing Group
Nature Portfolio
Subjects
631/67/1504/1610/4029
631/67/327
Bile Duct Neoplasms - genetics
Bile Ducts, Intrahepatic
Biology
Biomedical and Life Sciences
Carcinoma, Hepatocellular - pathology
Cholangiocarcinoma
Cholangiocarcinoma - genetics
Endothelial cells
Endothelial Cells - metabolism
Fibroblasts
Hepatocellular carcinoma
Heterogeneity
Humans
Life Sciences
Liver cancer
Liver Neoplasms - pathology
Lymphocytes T
Microenvironments
Phenotypes
Transcriptomics
Tumor Microenvironment - genetics
Tumors
Online AccessGet full text

Cover

Abstract Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE + intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies. A comprehensive multi-omic, single-cell, and spatial analysis provides further insight into the major cell types present in three types of primary liver cancer.
AbstractList Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE+ intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.A comprehensive multi-omic, single-cell, and spatial analysis provides further insight into the major cell types present in three types of primary liver cancer.
Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE + intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.
Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE + intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies. A comprehensive multi-omic, single-cell, and spatial analysis provides further insight into the major cell types present in three types of primary liver cancer.
Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.
Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE+ intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE+ intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.
Abstract Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE+ intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.
ArticleNumber 1181
Author Zhou, Jian
Zhu, Gui-Qi
Jiang, Xi-Fei
Liu, Wei-Ren
Huang, Cheng
Sun, Bao-Ye
Shi, Ying-Hong
Fang, Yuan
Gao, Qiang
Tian, Meng-Xin
Liu, Gao
Fan, Jia
Tang, Zheng
Huang, Run
Tao, Chen-Yang
Yi, Yong
Huang, Jin-Long
Qu, Wei-Feng
Fu, Xiu-Tao
Zhou, Cheng
Qiu, Shuang-Jian
Gan, Wei
Zhou, Pei-Yun
Wang, Han
Ding, Zhen-Bin
Author_xml – sequence: 1
  givenname: Pei-Yun
  orcidid: 0009-0008-2699-8477
  surname: Zhou
  fullname: Zhou, Pei-Yun
  email: maikestar99@163.com
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai Cancer Center, Fudan University
– sequence: 2
  givenname: Cheng
  surname: Zhou
  fullname: Zhou, Cheng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 3
  givenname: Wei
  surname: Gan
  fullname: Gan, Wei
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 4
  givenname: Zheng
  surname: Tang
  fullname: Tang, Zheng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 5
  givenname: Bao-Ye
  orcidid: 0000-0002-6802-5904
  surname: Sun
  fullname: Sun, Bao-Ye
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 6
  givenname: Jin-Long
  surname: Huang
  fullname: Huang, Jin-Long
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 7
  givenname: Gao
  surname: Liu
  fullname: Liu, Gao
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 8
  givenname: Wei-Ren
  surname: Liu
  fullname: Liu, Wei-Ren
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 9
  givenname: Meng-Xin
  surname: Tian
  fullname: Tian, Meng-Xin
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 10
  givenname: Xi-Fei
  surname: Jiang
  fullname: Jiang, Xi-Fei
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 11
  givenname: Han
  surname: Wang
  fullname: Wang, Han
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 12
  givenname: Chen-Yang
  surname: Tao
  fullname: Tao, Chen-Yang
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 13
  givenname: Yuan
  surname: Fang
  fullname: Fang, Yuan
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 14
  givenname: Wei-Feng
  surname: Qu
  fullname: Qu, Wei-Feng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 15
  givenname: Run
  surname: Huang
  fullname: Huang, Run
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 16
  givenname: Gui-Qi
  orcidid: 0000-0001-5089-6923
  surname: Zhu
  fullname: Zhu, Gui-Qi
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 17
  givenname: Cheng
  surname: Huang
  fullname: Huang, Cheng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 18
  givenname: Xiu-Tao
  surname: Fu
  fullname: Fu, Xiu-Tao
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 19
  givenname: Zhen-Bin
  orcidid: 0000-0001-6613-8270
  surname: Ding
  fullname: Ding, Zhen-Bin
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 20
  givenname: Qiang
  surname: Gao
  fullname: Gao, Qiang
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 21
  givenname: Jian
  orcidid: 0000-0002-2118-1117
  surname: Zhou
  fullname: Zhou, Jian
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 22
  givenname: Ying-Hong
  surname: Shi
  fullname: Shi, Ying-Hong
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 23
  givenname: Yong
  orcidid: 0000-0003-0847-2590
  surname: Yi
  fullname: Yi, Yong
  email: yi.yong@zs-hospital.sh.cn
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 24
  givenname: Jia
  orcidid: 0000-0001-5158-629X
  surname: Fan
  fullname: Fan, Jia
  email: fan.jia@zs-hospital.sh.cn
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
– sequence: 25
  givenname: Shuang-Jian
  orcidid: 0000-0002-2659-472X
  surname: Qiu
  fullname: Qiu, Shuang-Jian
  email: qiu.shuangjian@zs-hospital.sh.cn
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37985711$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9v1DAQxS1UREvpF-CAInHhEvDfOJa4oIqWSpU4AGdrYo8Xr7LxYieV-PZ4my2gHnqwPBr93tPMvJfkZEoTEvKa0feMiv5DkZxS0VJen5JKtfQZOePCmFZ0kp_8V5-Si1K2lFJmjOmEfEFOhTa90oydkY_f4rQZsXU4jg1Mvil7mCPUOrufcUY3LxmbFJp9jjvIv5sx3mFuHEwO8yvyPMBY8OL4n5MfV5-_X35pb79e31x-um2dUmxue8GY18YwjwwGrYNiyiFQ7oAb7_TAh85TNRhtuO-kRj-EIJzy0kDXAYhzcrP6-gRbe5zEJoj2vpHyxkKeoxvR1qU6GLgIEJT0Do2j0qjOa0Zpr0Jfvd6tXvucfi1YZruL5bA9TJiWYnlvONdcKF7Rt4_QbVryVDc9UJLKSh0M3xypZdih_zvew40r0K-Ay6mUjMG6ONcjp2nOEEfLqD0katdEbU3U3idqaZXyR9IH9ydFYhWVCk8bzP_GfkL1B6ZisFo
CitedBy_id crossref_primary_10_1097_HC9_0000000000000540
crossref_primary_10_1038_s41575_024_01024_w
crossref_primary_10_1055_a_2299_7880
crossref_primary_10_1002_ctm2_70036
crossref_primary_10_20517_mtod_2024_64
crossref_primary_10_1016_j_jhepr_2024_101094
crossref_primary_10_1016_j_trecan_2024_11_005
crossref_primary_10_1186_s40364_024_00622_9
crossref_primary_10_1186_s12943_024_02040_9
crossref_primary_10_1016_j_cca_2024_119814
crossref_primary_10_3389_fimmu_2024_1474869
crossref_primary_10_3892_mmr_2025_13431
Cites_doi 10.1002/hep.29353
10.1126/science.aan6733
10.1038/s41576-019-0114-6
10.1016/j.cell.2018.05.060
10.1002/hep.30863
10.1016/j.pharmthera.2018.05.001
10.1016/j.celrep.2017.02.033
10.1016/j.cell.2019.11.025
10.1038/s41591-018-0096-5
10.1038/s41586-019-1373-2
10.1016/j.jhep.2018.02.029
10.4049/jimmunol.1201431
10.1016/j.cell.2019.10.003
10.1038/s41586-018-0414-6
10.1126/science.aaf2403
10.1056/NEJMoa1504627
10.1038/s41467-019-08380-1
10.1016/j.cell.2019.08.052
10.1016/j.ccell.2019.08.007
10.1002/hep.25874
10.1016/j.jhep.2020.05.039
10.1186/s12859-015-0613-1
10.1016/j.ccell.2019.04.007
10.1016/j.cell.2020.08.040
10.1056/NEJMoa1003466
10.1038/cr.2018.11
10.1016/S1470-2045(18)30351-6
10.1016/j.ccell.2017.05.009
10.1186/s12935-021-02252-9
10.4103/apjon.apjon_79_17
10.1038/s41587-019-0392-8
10.21037/hbsn-20-338
10.1200/JCO.2017.76.9901
10.1016/j.cell.2017.05.035
10.1038/s41417-021-00309-5
10.1016/S0140-6736(15)01281-7
10.1093/bioinformatics/btv715
10.1016/j.cell.2017.05.046
10.1016/j.ygeno.2021.12.008
10.3322/caac.21338
10.1056/NEJMoa1915745
10.1038/s41467-021-27220-9
10.1136/gutjnl-2019-318912
10.1038/sj.emboj.7600282
10.1056/NEJMoa1606774
10.1038/s41571-021-00546-5
10.1038/s41568-019-0238-1
10.1038/s41586-019-0987-8
10.1056/NEJMoa2017699
10.1038/nature21065
10.3322/caac.21590
10.1016/S0140-6736(17)31046-2
10.1016/S1470-2045(20)30109-1
10.1038/s41591-018-0078-7
10.1038/s41467-018-03276-y
10.1016/j.cell.2020.11.041
10.1038/ncomms6696
10.1080/15548627.2021.1886839
10.1038/s41587-021-00830-w
10.1038/s41586-020-2157-4
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88I
8FE
8FH
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.1038/s42003-023-05455-0
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2399-3642
EndPage 17
ExternalDocumentID oai_doaj_org_article_7116ab23faf54dce9c04956d710085f8
37985711
10_1038_s42003_023_05455_0
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
53G
88I
AAJSJ
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
AFKRA
AJTQC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
C6C
CCPQU
DWQXO
EBLON
EBS
GNUQQ
GROUPED_DOAJ
HCIFZ
HYE
M2P
M7P
M~E
NAO
O9-
OK1
PGMZT
PIMPY
RNT
RPM
SNYQT
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FE
8FH
8FK
AARCD
LK8
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c551t-8311d7991de1ab77f515cea02ca29dc7b2b6d05b9792d647edbff3c5d49a66aa3
IEDL.DBID AAJSJ
ISSN 2399-3642
IngestDate Wed Aug 27 01:21:40 EDT 2025
Fri Jul 11 00:40:29 EDT 2025
Wed Aug 13 03:18:49 EDT 2025
Thu Apr 03 07:01:22 EDT 2025
Tue Jul 01 03:01:51 EDT 2025
Thu Apr 24 22:59:50 EDT 2025
Fri Feb 21 02:38:38 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c551t-8311d7991de1ab77f515cea02ca29dc7b2b6d05b9792d647edbff3c5d49a66aa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6802-5904
0009-0008-2699-8477
0000-0002-2118-1117
0000-0001-6613-8270
0000-0002-2659-472X
0000-0001-5158-629X
0000-0001-5089-6923
0000-0003-0847-2590
OpenAccessLink https://www.nature.com/articles/s42003-023-05455-0
PMID 37985711
PQID 2894042358
PQPubID 4669726
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_7116ab23faf54dce9c04956d710085f8
proquest_miscellaneous_2892272352
proquest_journals_2894042358
pubmed_primary_37985711
crossref_citationtrail_10_1038_s42003_023_05455_0
crossref_primary_10_1038_s42003_023_05455_0
springer_journals_10_1038_s42003_023_05455_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-20
PublicationDateYYYYMMDD 2023-11-20
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Communications biology
PublicationTitleAbbrev Commun Biol
PublicationTitleAlternate Commun Biol
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Sahai (CR44) 2020; 20
Zhang (CR14) 2019; 68
Lambrechts (CR48) 2018; 24
Richardson, Jadlowsky, Didigu, Doms, Riley (CR47) 2012; 189
Chen, McAndrews, Kalluri (CR53) 2021; 18
Jiang (CR35) 2019; 567
CR38
CR36
Azizi (CR49) 2018; 174
Herbst (CR50) 2016; 387
Finn (CR15) 2020; 382
Zhang (CR21) 2020; 73
CR30
Yang (CR8) 2017; 66
(CR12) 2017; 169
He, Feng, An, Liu, Xiang (CR40) 2022; 114
Zheng, Liu, Ge, Wang (CR54) 2021; 21
Gao (CR32) 2019; 179
Andre (CR59) 2020; 383
Ma (CR6) 2019; 36
Mathur (CR41) 2018; 190
Zhu (CR19) 2018; 19
Aizarani (CR13) 2019; 572
El-Khoueiry (CR17) 2017; 389
Zhang (CR23) 2019; 179
Dong (CR42) 2018; 69
Abou-Alfa (CR45) 2020; 21
Lin (CR16) 2020; 9
Wang, Luo, Zhang, Younis, Yuan (CR37) 2021
Nazarov (CR61) 2015; 16
Xue (CR4) 2019; 35
Savas (CR26) 2018; 24
Cai (CR5) 2012; 56
Chaisaingmongkol (CR56) 2017; 32
Zheng (CR22) 2017; 169
Halpern (CR7) 2017; 542
Turajlic, Sottoriva, Graham, Swanton (CR33) 2019; 20
Eferl (CR39) 2004; 23
Munne (CR46) 2021; 12
Asp (CR27) 2019; 179
Chen (CR2) 2016; 66
Le (CR18) 2017; 357
Wilkes (CR9) 2018; 5
Duan (CR11) 2018; 28
Brahmer (CR52) 2015; 373
Sharma (CR25) 2020; 183
La Manno (CR34) 2018; 560
Reck (CR51) 2016; 375
Lu (CR31) 2020; 71
Overman (CR58) 2018; 36
Farshidfar (CR10) 2017; 18
Siegel, Miller, Jemal (CR1) 2020; 70
Moncada (CR28) 2020; 38
Wang (CR55) 2018; 9
CR24
CR20
Angerer (CR60) 2016; 32
Hodi (CR57) 2010; 363
Bray (CR3) 2018; 68
Stahl (CR29) 2016; 353
Xue (CR43) 2019; 10
M Reck (5455_CR51) 2016; 375
M Asp (5455_CR27) 2019; 179
R Xue (5455_CR4) 2019; 35
J Lin (5455_CR16) 2020; 9
F Wang (5455_CR37) 2021
5455_CR38
L Ma (5455_CR6) 2019; 36
5455_CR36
5455_CR30
VI Nazarov (5455_CR61) 2015; 16
AB El-Khoueiry (5455_CR17) 2017; 389
S Turajlic (5455_CR33) 2019; 20
PM Munne (5455_CR46) 2021; 12
RS Finn (5455_CR15) 2020; 382
DT Le (5455_CR18) 2017; 357
F Bray (5455_CR3) 2018; 68
Y Jiang (5455_CR35) 2019; 567
A Wang (5455_CR55) 2018; 9
M Duan (5455_CR11) 2018; 28
A Sharma (5455_CR25) 2020; 183
Y Xue (5455_CR43) 2019; 10
E Sahai (5455_CR44) 2020; 20
E Azizi (5455_CR49) 2018; 174
FS Hodi (5455_CR57) 2010; 363
RL Siegel (5455_CR1) 2020; 70
Q Gao (5455_CR32) 2019; 179
G La Manno (5455_CR34) 2018; 560
T Andre (5455_CR59) 2020; 383
J Chaisaingmongkol (5455_CR56) 2017; 32
R Eferl (5455_CR39) 2004; 23
Q Zhang (5455_CR23) 2019; 179
R Mathur (5455_CR41) 2018; 190
C Zheng (5455_CR22) 2017; 169
GM Wilkes (5455_CR9) 2018; 5
LQ Dong (5455_CR42) 2018; 69
AX Zhu (5455_CR19) 2018; 19
X Cai (5455_CR5) 2012; 56
PL Stahl (5455_CR29) 2016; 353
Cancer Genome Atlas Research Network. Electronic address, w. b. e.Cancer Genome Atlas Research, N. (5455_CR12) 2017; 169
MJ Overman (5455_CR58) 2018; 36
KB Halpern (5455_CR7) 2017; 542
Q Zhang (5455_CR14) 2019; 68
J Brahmer (5455_CR52) 2015; 373
N Aizarani (5455_CR13) 2019; 572
K He (5455_CR40) 2022; 114
M Zhang (5455_CR21) 2020; 73
GK Abou-Alfa (5455_CR45) 2020; 21
Y Chen (5455_CR53) 2021; 18
P Savas (5455_CR26) 2018; 24
D Lambrechts (5455_CR48) 2018; 24
5455_CR24
MW Richardson (5455_CR47) 2012; 189
W Chen (5455_CR2) 2016; 66
5455_CR20
P Angerer (5455_CR60) 2016; 32
F Farshidfar (5455_CR10) 2017; 18
R Moncada (5455_CR28) 2020; 38
RS Herbst (5455_CR50) 2016; 387
L Yang (5455_CR8) 2017; 66
H Zheng (5455_CR54) 2021; 21
ZN Lu (5455_CR31) 2020; 71
References_xml – volume: 66
  start-page: 1387
  year: 2017
  end-page: 1401
  ident: CR8
  article-title: A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation
  publication-title: Hepatology
  doi: 10.1002/hep.29353
– volume: 357
  start-page: 409
  year: 2017
  end-page: 413
  ident: CR18
  article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
  publication-title: Science
  doi: 10.1126/science.aan6733
– volume: 20
  start-page: 404
  year: 2019
  end-page: 416
  ident: CR33
  article-title: Resolving genetic heterogeneity in cancer
  publication-title: Nat. Rev. Genet
  doi: 10.1038/s41576-019-0114-6
– volume: 174
  start-page: 1293
  year: 2018
  end-page: 1308.e1236
  ident: CR49
  article-title: Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
  publication-title: Cell
  doi: 10.1016/j.cell.2018.05.060
– volume: 71
  start-page: 929
  year: 2020
  end-page: 942
  ident: CR31
  article-title: The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers
  publication-title: Hepatology
  doi: 10.1002/hep.30863
– volume: 190
  start-page: 15
  year: 2018
  end-page: 23
  ident: CR41
  article-title: ARID1A loss in cancer: Towards a mechanistic understanding
  publication-title: Pharm. Ther.
  doi: 10.1016/j.pharmthera.2018.05.001
– volume: 18
  start-page: 2780
  year: 2017
  end-page: 2794
  ident: CR10
  article-title: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.02.033
– volume: 179
  start-page: 1647
  year: 2019
  end-page: 1660.e1619
  ident: CR27
  article-title: A Spatiotemporal Organ-Wide Gene Expression and Cell Atlas of the Developing Human Heart
  publication-title: Cell
  doi: 10.1016/j.cell.2019.11.025
– volume: 24
  start-page: 1277
  year: 2018
  end-page: 1289
  ident: CR48
  article-title: Phenotype molding of stromal cells in the lung tumor microenvironment
  publication-title: Nat. Med
  doi: 10.1038/s41591-018-0096-5
– volume: 572
  start-page: 199
  year: 2019
  end-page: 204
  ident: CR13
  article-title: A human liver cell atlas reveals heterogeneity and epithelial progenitors
  publication-title: Nature
  doi: 10.1038/s41586-019-1373-2
– volume: 69
  start-page: 89
  year: 2018
  end-page: 98
  ident: CR42
  article-title: Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2018.02.029
– volume: 189
  start-page: 3815
  year: 2012
  end-page: 3821
  ident: CR47
  article-title: Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1201431
– volume: 179
  start-page: 829
  year: 2019
  end-page: 845.e820
  ident: CR23
  article-title: Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.003
– volume: 560
  start-page: 494
  year: 2018
  end-page: 498
  ident: CR34
  article-title: RNA velocity of single cells
  publication-title: Nature
  doi: 10.1038/s41586-018-0414-6
– volume: 353
  start-page: 78
  year: 2016
  end-page: 82
  ident: CR29
  article-title: Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
  publication-title: Science
  doi: 10.1126/science.aaf2403
– volume: 373
  start-page: 123
  year: 2015
  end-page: 135
  ident: CR52
  article-title: Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1504627
– volume: 10
  year: 2019
  ident: CR43
  article-title: SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-08380-1
– volume: 179
  start-page: 561
  year: 2019
  end-page: 577.e522
  ident: CR32
  article-title: Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2019.08.052
– volume: 36
  start-page: 418
  year: 2019
  end-page: 430.e416
  ident: CR6
  article-title: Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.08.007
– volume: 56
  start-page: 1804
  year: 2012
  end-page: 1816
  ident: CR5
  article-title: Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.25874
– volume: 73
  start-page: 1118
  year: 2020
  end-page: 1130
  ident: CR21
  article-title: Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2020.05.039
– volume: 16
  year: 2015
  ident: CR61
  article-title: tcR: an R package for T cell receptor repertoire advanced data analysis
  publication-title: BMC Bioinforma.
  doi: 10.1186/s12859-015-0613-1
– volume: 35
  start-page: 932
  year: 2019
  end-page: 947.e938
  ident: CR4
  article-title: Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.04.007
– volume: 183
  start-page: 377
  year: 2020
  end-page: 394.e321
  ident: CR25
  article-title: Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.040
– ident: CR36
– volume: 363
  start-page: 711
  year: 2010
  end-page: 723
  ident: CR57
  article-title: Improved survival with ipilimumab in patients with metastatic melanoma
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1003466
– volume: 28
  start-page: 359
  year: 2018
  end-page: 373
  ident: CR11
  article-title: Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing
  publication-title: Cell Res
  doi: 10.1038/cr.2018.11
– volume: 19
  start-page: 940
  year: 2018
  end-page: 952
  ident: CR19
  article-title: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(18)30351-6
– volume: 32
  start-page: 57
  year: 2017
  end-page: 70.e53
  ident: CR56
  article-title: Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.05.009
– volume: 21
  year: 2021
  ident: CR54
  article-title: Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-02252-9
– volume: 5
  start-page: 137
  year: 2018
  end-page: 155
  ident: CR9
  article-title: Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
  publication-title: Asia Pac. J. Oncol. Nurs.
  doi: 10.4103/apjon.apjon_79_17
– volume: 38
  start-page: 333
  year: 2020
  end-page: 342
  ident: CR28
  article-title: Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-019-0392-8
– volume: 9
  start-page: 414
  year: 2020
  end-page: 424
  ident: CR16
  article-title: Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma
  publication-title: Hepatob. Surg. Nutr.
  doi: 10.21037/hbsn-20-338
– volume: 36
  start-page: 773
  year: 2018
  end-page: 779
  ident: CR58
  article-title: Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.9901
– volume: 169
  start-page: 1342
  year: 2017
  end-page: 1356.e1316
  ident: CR22
  article-title: Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.035
– ident: CR30
– year: 2021
  ident: CR37
  article-title: The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway
  publication-title: Cancer Gene Ther.
  doi: 10.1038/s41417-021-00309-5
– volume: 387
  start-page: 1540
  year: 2016
  end-page: 1550
  ident: CR50
  article-title: Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01281-7
– volume: 32
  start-page: 1241
  year: 2016
  end-page: 1243
  ident: CR60
  article-title: destiny: diffusion maps for large-scale single-cell data in R
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv715
– volume: 169
  start-page: 1327
  year: 2017
  end-page: 1341.e1323
  ident: CR12
  article-title: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.046
– volume: 114
  start-page: 241
  year: 2022
  end-page: 252
  ident: CR40
  article-title: Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2021.12.008
– volume: 66
  start-page: 115
  year: 2016
  end-page: 132
  ident: CR2
  article-title: Cancer statistics in China, 2015
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21338
– volume: 382
  start-page: 1894
  year: 2020
  end-page: 1905
  ident: CR15
  article-title: Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1915745
– volume: 12
  year: 2021
  ident: CR46
  article-title: Compressive stress-mediated p38 activation required for ERalpha + phenotype in breast cancer
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27220-9
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: CR3
  article-title: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
  publication-title: CA: a cancer J. Clin.
– volume: 68
  start-page: 2019
  year: 2019
  end-page: 2031
  ident: CR14
  article-title: Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318912
– volume: 23
  start-page: 2789
  year: 2004
  end-page: 2799
  ident: CR39
  article-title: The Fos-related antigen Fra-1 is an activator of bone matrix formation
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600282
– ident: CR38
– volume: 375
  start-page: 1823
  year: 2016
  end-page: 1833
  ident: CR51
  article-title: Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1606774
– volume: 18
  start-page: 792
  year: 2021
  end-page: 804
  ident: CR53
  article-title: Clinical and therapeutic relevance of cancer-associated fibroblasts
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-021-00546-5
– volume: 20
  start-page: 174
  year: 2020
  end-page: 186
  ident: CR44
  article-title: A framework for advancing our understanding of cancer-associated fibroblasts
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0238-1
– volume: 567
  start-page: 257
  year: 2019
  end-page: 261
  ident: CR35
  article-title: Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
  publication-title: Nature
  doi: 10.1038/s41586-019-0987-8
– volume: 383
  start-page: 2207
  year: 2020
  end-page: 2218
  ident: CR59
  article-title: Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa2017699
– volume: 542
  start-page: 352
  year: 2017
  end-page: 356
  ident: CR7
  article-title: Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
  publication-title: Nature
  doi: 10.1038/nature21065
– volume: 70
  start-page: 7
  year: 2020
  end-page: 30
  ident: CR1
  article-title: Cancer statistics, 2020
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21590
– volume: 389
  start-page: 2492
  year: 2017
  end-page: 2502
  ident: CR17
  article-title: Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31046-2
– volume: 21
  start-page: 671
  year: 2020
  end-page: 684
  ident: CR45
  article-title: Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(20)30109-1
– ident: CR24
– ident: CR20
– volume: 24
  start-page: 986
  year: 2018
  end-page: 993
  ident: CR26
  article-title: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
  publication-title: Nat. Med
  doi: 10.1038/s41591-018-0078-7
– volume: 9
  year: 2018
  ident: CR55
  article-title: Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03276-y
– volume: 169
  start-page: 1342
  year: 2017
  ident: 5455_CR22
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.035
– volume: 183
  start-page: 377
  year: 2020
  ident: 5455_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.040
– volume: 16
  year: 2015
  ident: 5455_CR61
  publication-title: BMC Bioinforma.
  doi: 10.1186/s12859-015-0613-1
– volume: 387
  start-page: 1540
  year: 2016
  ident: 5455_CR50
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01281-7
– volume: 179
  start-page: 829
  year: 2019
  ident: 5455_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.003
– volume: 10
  year: 2019
  ident: 5455_CR43
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-08380-1
– volume: 560
  start-page: 494
  year: 2018
  ident: 5455_CR34
  publication-title: Nature
  doi: 10.1038/s41586-018-0414-6
– volume: 174
  start-page: 1293
  year: 2018
  ident: 5455_CR49
  publication-title: Cell
  doi: 10.1016/j.cell.2018.05.060
– volume: 389
  start-page: 2492
  year: 2017
  ident: 5455_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31046-2
– ident: 5455_CR38
  doi: 10.1016/j.cell.2020.11.041
– volume: 23
  start-page: 2789
  year: 2004
  ident: 5455_CR39
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600282
– volume: 19
  start-page: 940
  year: 2018
  ident: 5455_CR19
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(18)30351-6
– volume: 21
  year: 2021
  ident: 5455_CR54
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-02252-9
– volume: 169
  start-page: 1327
  year: 2017
  ident: 5455_CR12
  publication-title: Cell
  doi: 10.1016/j.cell.2017.05.046
– volume: 38
  start-page: 333
  year: 2020
  ident: 5455_CR28
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-019-0392-8
– volume: 69
  start-page: 89
  year: 2018
  ident: 5455_CR42
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2018.02.029
– volume: 56
  start-page: 1804
  year: 2012
  ident: 5455_CR5
  publication-title: Hepatology
  doi: 10.1002/hep.25874
– volume: 383
  start-page: 2207
  year: 2020
  ident: 5455_CR59
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa2017699
– volume: 36
  start-page: 418
  year: 2019
  ident: 5455_CR6
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.08.007
– volume: 32
  start-page: 57
  year: 2017
  ident: 5455_CR56
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.05.009
– volume: 24
  start-page: 1277
  year: 2018
  ident: 5455_CR48
  publication-title: Nat. Med
  doi: 10.1038/s41591-018-0096-5
– volume: 24
  start-page: 986
  year: 2018
  ident: 5455_CR26
  publication-title: Nat. Med
  doi: 10.1038/s41591-018-0078-7
– volume: 353
  start-page: 78
  year: 2016
  ident: 5455_CR29
  publication-title: Science
  doi: 10.1126/science.aaf2403
– year: 2021
  ident: 5455_CR37
  publication-title: Cancer Gene Ther.
  doi: 10.1038/s41417-021-00309-5
– volume: 70
  start-page: 7
  year: 2020
  ident: 5455_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21590
– volume: 20
  start-page: 174
  year: 2020
  ident: 5455_CR44
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0238-1
– volume: 66
  start-page: 1387
  year: 2017
  ident: 5455_CR8
  publication-title: Hepatology
  doi: 10.1002/hep.29353
– volume: 375
  start-page: 1823
  year: 2016
  ident: 5455_CR51
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1606774
– ident: 5455_CR20
  doi: 10.1038/ncomms6696
– volume: 373
  start-page: 123
  year: 2015
  ident: 5455_CR52
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1504627
– volume: 66
  start-page: 115
  year: 2016
  ident: 5455_CR2
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21338
– volume: 18
  start-page: 792
  year: 2021
  ident: 5455_CR53
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-021-00546-5
– volume: 114
  start-page: 241
  year: 2022
  ident: 5455_CR40
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2021.12.008
– volume: 179
  start-page: 1647
  year: 2019
  ident: 5455_CR27
  publication-title: Cell
  doi: 10.1016/j.cell.2019.11.025
– volume: 189
  start-page: 3815
  year: 2012
  ident: 5455_CR47
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1201431
– volume: 542
  start-page: 352
  year: 2017
  ident: 5455_CR7
  publication-title: Nature
  doi: 10.1038/nature21065
– volume: 20
  start-page: 404
  year: 2019
  ident: 5455_CR33
  publication-title: Nat. Rev. Genet
  doi: 10.1038/s41576-019-0114-6
– volume: 357
  start-page: 409
  year: 2017
  ident: 5455_CR18
  publication-title: Science
  doi: 10.1126/science.aan6733
– volume: 9
  year: 2018
  ident: 5455_CR55
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03276-y
– volume: 28
  start-page: 359
  year: 2018
  ident: 5455_CR11
  publication-title: Cell Res
  doi: 10.1038/cr.2018.11
– volume: 71
  start-page: 929
  year: 2020
  ident: 5455_CR31
  publication-title: Hepatology
  doi: 10.1002/hep.30863
– ident: 5455_CR36
  doi: 10.1080/15548627.2021.1886839
– volume: 190
  start-page: 15
  year: 2018
  ident: 5455_CR41
  publication-title: Pharm. Ther.
  doi: 10.1016/j.pharmthera.2018.05.001
– volume: 73
  start-page: 1118
  year: 2020
  ident: 5455_CR21
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2020.05.039
– volume: 35
  start-page: 932
  year: 2019
  ident: 5455_CR4
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.04.007
– volume: 21
  start-page: 671
  year: 2020
  ident: 5455_CR45
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(20)30109-1
– volume: 18
  start-page: 2780
  year: 2017
  ident: 5455_CR10
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.02.033
– volume: 567
  start-page: 257
  year: 2019
  ident: 5455_CR35
  publication-title: Nature
  doi: 10.1038/s41586-019-0987-8
– ident: 5455_CR30
  doi: 10.1038/s41587-021-00830-w
– volume: 179
  start-page: 561
  year: 2019
  ident: 5455_CR32
  publication-title: Cell
  doi: 10.1016/j.cell.2019.08.052
– ident: 5455_CR24
  doi: 10.1038/s41586-020-2157-4
– volume: 572
  start-page: 199
  year: 2019
  ident: 5455_CR13
  publication-title: Nature
  doi: 10.1038/s41586-019-1373-2
– volume: 363
  start-page: 711
  year: 2010
  ident: 5455_CR57
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa1003466
– volume: 12
  year: 2021
  ident: 5455_CR46
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27220-9
– volume: 68
  start-page: 2019
  year: 2019
  ident: 5455_CR14
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318912
– volume: 68
  start-page: 394
  year: 2018
  ident: 5455_CR3
  publication-title: CA: a cancer J. Clin.
– volume: 382
  start-page: 1894
  year: 2020
  ident: 5455_CR15
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1915745
– volume: 5
  start-page: 137
  year: 2018
  ident: 5455_CR9
  publication-title: Asia Pac. J. Oncol. Nurs.
  doi: 10.4103/apjon.apjon_79_17
– volume: 32
  start-page: 1241
  year: 2016
  ident: 5455_CR60
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv715
– volume: 9
  start-page: 414
  year: 2020
  ident: 5455_CR16
  publication-title: Hepatob. Surg. Nutr.
  doi: 10.21037/hbsn-20-338
– volume: 36
  start-page: 773
  year: 2018
  ident: 5455_CR58
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.9901
SSID ssj0001999634
Score 2.3351288
Snippet Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and...
Abstract Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity...
SourceID doaj
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1181
SubjectTerms 631/67/1504/1610/4029
631/67/327
Bile Duct Neoplasms - genetics
Bile Ducts, Intrahepatic
Biology
Biomedical and Life Sciences
Carcinoma, Hepatocellular - pathology
Cholangiocarcinoma
Cholangiocarcinoma - genetics
Endothelial cells
Endothelial Cells - metabolism
Fibroblasts
Hepatocellular carcinoma
Heterogeneity
Humans
Life Sciences
Liver cancer
Liver Neoplasms - pathology
Lymphocytes T
Microenvironments
Phenotypes
Transcriptomics
Tumor Microenvironment - genetics
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et_VFBW8abPNswIuKIh68qOAt5HlauuLuHvz3TtLuuuLr4rWZaZP5GuZLMplB6LiJSkYhPXasCTjtMWBDhMOSOBMtZ9Z3Ub734vaJ3T3z57lSXykmrEsP3BnuTNa1MJbQaCJn3gXlqsTpfc5Kw2O-5gs-b24xlXdXEo-nrL8lU9HmbMRyGBa4KAwshXNcffJEOWH_dyzzywlpdjw3q2ilZ4zlRdfTNbQQ2nW01NWQfNtA5w-gNQg47cCXpvXlKMVIg8L8EUE5jOVLl1eiHKRIjNIltF830dPN9ePVLe5LImAH1GaMG1rXXgKn86E2VsoIdMQFU4FlifJOWmIFWNcqqYgXTAZvY6SOe6aMEMbQLbTYDtuwg8ooY0rMExshJMvqVDHqYb0XFFc2Fqiemke7Pl94Klsx0Pncmja6M6kGk-psUl0V6GSm04_qV-nLZPWZZMp0nR8A_rrHX_-Ff4H2p5jpfvqNNKwiWQr44dB8NGuGiZOwMG0YTrIMIRJkSIG2O6xnPaFSNRy-XKDTKfgfL_95QLv_MaA9tJxK2qf7jqTaR4vj10k4AOIztof5H38HH3_59A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVkhcEOXVQIuCxA2sJn5bQqooalVxqBBQqTfLTy6rpOxuD_33tR3vbhHQazKT2DN-fJ4ZzwC8l1GJyIVHjsqAso0BGcwdEtiZaBm1foryPednF_TrJbusBrdlDatcr4llofajyzbyw3QwoDmGg8mjq98oV43K3tVaQuMh7KQlWMoZ7ByfnH_7vrWyZDxPaL0t0xF5uKQlHCttVSihFcZQ98eOVBL3_wtt_uUpLRvQ6VN4UpFj-3lS9S48CMMzeDTVkrx5Dp9-JK55QNkS35rBt8scK50Y7roK2jG2V1N-iXaeIzJal7W-eAEXpyc_v5yhWhoBuQRxVkiSvvciYTsfemOFiAmWuGC6JGGsvBMWW56kbJVQ2HMqgrcxEsc8VYZzY8hLmA3jEPagjSLmBD1Rci5oYSeKEp_OfUExZWMD_Vo82tW84bl8xVwX_zWRehKpTiLVRaS6a-DDhqf26l7q4yz1DWXOeF0ejItfuk4gLfqeG4tJNJFR74JyXT7b-ZKdiEXZwP5aZ7pOw6XeDpoG3m1epwmUdWGGMF4XGoxFosENvJp0vWkJEUqy9OcGPq6Vv_34_zv0-v62vIHHuWh9vtGIu32YrRbX4SBBm5V9W8fvLUPJ8yQ
  priority: 102
  providerName: ProQuest
Title Single-cell and spatial architecture of primary liver cancer
URI https://link.springer.com/article/10.1038/s42003-023-05455-0
https://www.ncbi.nlm.nih.gov/pubmed/37985711
https://www.proquest.com/docview/2894042358
https://www.proquest.com/docview/2892272352
https://doaj.org/article/7116ab23faf54dce9c04956d710085f8
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEG8CZRUkbmCR-BlLXLarVtUeKkSp1JvlJ5dVFu1uD_x7xk6yBVGQOEVKZhJ7xo5nxuNvAN51SaskVSCed5HkGAOxVHqiqLfJCe7CkOV7Ic-v-PJaXB8Anc7ClKT9AmlZftNTdtjHLS9ZVLjCEDQyhCDoph9lqHYc20fz-fJyeRtZyTY84-MJmYZ1dzD_tgoVsP67LMw_dkfLonP2CB6O1mI9H9r3GA5i_wTuD_UjfzyFT5fItYokR99r24d6m_OjkeHX7YF6nervA6ZEvcpZGLXPmt48g6uz06-LczKWQyAezZod6VjbBoX2XIitdUolNEV8tA1KlerglaNOomSdVpoGyVUMLiXmReDaSmktew6H_bqPL6FOKmVQntRJqXhhZ5qzgL5e1EK7VEE7icf4ESs8l6xYmbJnzToziNSgSE0RqWkqeL_nGXv1T-qTLPU9ZUa5LjfWm29m1LpRbSutoyzZJHjwUfsm-3OhIBKJ1FVwPOnMjFNva9CD5DnZR-Djt_vHOGmyLmwf1zeFhlKFNLSCF4Ou9y1hSncCv1zBh0n5ty__e4de_R_5a3iQC9fnU420OYbD3eYmvkHzZudm43jG68npxecvM7i3kItZCRb8BF239CU
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFS2QvSCeBMoECQ4gdXEz1gCIQqttrSsELRSb67jRy-rpOxuhfpTfCO2k-yCgN56TcaJPQ_PjGc8A_Ci8lJ4LiwytHIonjEgjblBAhvta0Zr22X5Tvj4iH46Zsdr8HO4CxPTKoc9MW3UtjXxjHwrOAY05nCw6t3ZdxS7RsXo6tBCo2OLfXfxI7hs87d7HwN9X2K8u3P4YYz6rgLIBOtggSpSllYEs8i6UtdC-KDRjdNFmByW1oga1zxMsJZCYsupcLb2nhhmqdSca03Cd6_BOiW8wCNY396ZfPm6OtWJ_gOh_e2cglRbc5rSv4JqRME6YgwVf2jA1CjgX9btX5HZpPB2b8HN3lLN33esdRvWXHMHrne9Ky_uwptvYdTUoXjyn-vG5vOYmx0G_B6ayFufn3X1LPJpzADJTeSy2T04uhKk3YdR0zbuIeRe-FgQyFecC5qGE0mJDX6mk0zWPoNyQI8yfZ3y2C5jqlK8nFSqQ6kKKFUJparI4NVyTL-qS6G3I9aXkLHCdnrQzk5VL7BKlCXXNSZee0atcdIU0Ze0qRoS81UGmwPNVC_2c7Vi0gyeL18HgY200I1rzxMMxiLA4AwedLRezoQIWbHw5wxeD8Rfffz_C3p0-VyewY3x4ecDdbA32X8MGzjyYlmG_XETRovZuXsSzKpF_bTn5RxOrlp8fgEPLzFa
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9QwzBo3gfaC-KZjQJHgCQJtkiaNBA8H47Td0IQ0Ju0tpPng5dSb7m5C-0P8Tpy0vYEYSDzstbHTxHZiO3FsgOd1UDII6YjltSfxjIEYKiyR1JrQVLxxXZTvodg75tOT6mQDfgxvYVLQfkppmbbpITrszZKnKCrUMASNjKoixetTF_pgygN__h1dteW7_V3k6wtKJx-_fNgjfTUBYtEqWJGalaWTaA45X5pGyoCa3HpT4KCoclY2tBE4sEZJRZ3g0rsmBGYrx5URwhiG_V6DTbTvSz6CzfF4ejS9OM2JfgPj_aucgtWXDPg3zZcKBFxm1f5xI5sU3eQW3Owt1Hzc0eQ2bPj2Dlzvalae34W3R4g18ySe-OemdfkyxmQjwq9XEvk85KddHot8FiM_chula3EPjq-EaPdh1M5b_xDyIENMBBRqISRP6Exx5tC_9KpSTcigHMijbZ-fPJbJmOl0T85q3ZFUI0l1IqkuMni5xuln9U_o95Hqa8iYWTt9mC--6V7StCxLYRrKggkVd9YrW0Qf0qUsSFWoM9gZeKb75b7U6LXyGGBUYfOzdTMu1MgL0_r5WYKhVCIMzeBBx-v1SJhUdYV_zuDVwPyLzv8-oe3_A38KNz7vTvSn_cODR7BFo2iWJW6TOzBaLc78Y7SuVs2TXrRz-HrVq-knUw8wHA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single-cell+and+spatial+architecture+of+primary+liver+cancer&rft.jtitle=Communications+biology&rft.au=Zhou%2C+Pei-Yun&rft.au=Zhou%2C+Cheng&rft.au=Gan%2C+Wei&rft.au=Tang%2C+Zheng&rft.date=2023-11-20&rft.issn=2399-3642&rft.eissn=2399-3642&rft.volume=6&rft.issue=1&rft.spage=1181&rft_id=info:doi/10.1038%2Fs42003-023-05455-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2399-3642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2399-3642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2399-3642&client=summon